Peter Van Vlasselaer, PhD

SR One thesis

Team Portfolio News Contact We are SR One Our Mission Transatlantic SR One A biotechnology venture capital firm, partnering with founders and entrepreneurs to translate innovative science into medicines. Meet the Team Scroll to discover more We are on a mission to power the arc of innovation from science to medicine SR One takes a back-and-build approach to its investments. Focusing on companies that we believe have strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases, SR One aims to help reimagine today’s science for tomorrow’s med

Sector and stage focus

• Series B: BioTech
• Seed: BioTech
• Series A: BioTech
• general: San Francisco Bay Area

Is Peter Van Vlasselaer, PhD a fit for your round?

Upload your pitch deck and see whether Peter Van Vlasselaer, PhD appears in your top 20 matches.